Home › Funds › Jones Hill Capital LP › XENE
Jones Hill Capital LP position in XENE
XENON PHARMACEUTICALS INC · Health Care
Jones Hill Capital LP reported holding 367,900 shares of XENE (XENON PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$22.2M, representing 4.72% of its reported portfolio and ranking #9 among its reported holdings. Jones Hill Capital LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Jones Hill Capital LP's XENE position evolved
Jones Hill Capital LP first disclosed a stake in XENE in Q2 2026 at 367,900 shares (US$22.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 367.90K | $22.21M | New |
About XENE and 13F data
XENE (XENON PHARMACEUTICALS INC) is a Health Care company. 44 other funds we track also report a position in XENE — the largest reported positions include Avoro Capital Advisors LLC (US$348.7M), Polar Capital Holdings Plc (US$275.9M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$266.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding XENE
- Avoro Capital Advisors LLC 5.78M sh · $348.75M · Q2 2026
- Polar Capital Holdings Plc 4.57M sh · $275.88M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 4.42M sh · $266.70M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.62M sh · $97.52M · Q2 2026
- Affinity Asset Advisors, LLC 1.59M sh · $96.27M · Q2 2026
- Siren, L.L.C. 1.32M sh · $79.59M · Q2 2026
- BRAIDWELL LP 1.13M sh · $68.29M · Q2 2026
- ORBIMED ADVISORS LLC 892.47K sh · $53.87M · Q2 2026
- Caligan Partners LP 889.94K sh · $53.72M · Q2 2026
- Caption Management, LLC 728.00K sh · $43.94M · Q2 2026
- Vestal Point Capital, LP 700.00K sh · $42.25M · Q2 2026
- Rock Springs Capital Management LP 683.91K sh · $41.28M · Q2 2026
More on Jones Hill Capital LP
FAQ
How long has Jones Hill Capital LP held XENE?
Jones Hill Capital LP has disclosed XENE holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Jones Hill Capital LP's current position in XENE?
As of Q2 2026, Jones Hill Capital LP holds 367.90K shares of XENE (XENON PHARMACEUTICALS INC), valued at $22.21M, representing 4.72% of its reported portfolio and ranking #9.
Has Jones Hill Capital LP been buying or selling XENE?
In the latest 13F filing (Q2 2026), Jones Hill Capital LP newly opened its position in XENE.
Which other funds hold XENE?
Other major institutional holders of XENE include Avoro Capital Advisors LLC, Polar Capital Holdings Plc, DRIEHAUS CAPITAL MANAGEMENT LLC, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.